Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Annals of Surgery|January 11, 2011
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activationEric Lutz, Charles J Yeo, Keith D Lillemoe, et al.The Journal of Clinical Investigation|March 15, 2023
HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formationLionel Chia, Bowen Wang, Jung-Hyun Kim, et al.Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.Journal of Proteome Research|September 19, 2012
Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs)Min-Sik Kim, Sarada V Kuppireddy, Sruthi Sakamuri, et al.The American Journal of Pathology|March 26, 2003
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarraysChristine A Iacobuzio-Donahue, Anirban Maitra, Mari Olsen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins HospitalJoseph M Herman, Michael J Swartz, Charles C Hsu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Personalized chemotherapy profiling using cancer cell lines from selectable miceHirohiko Kamiyama, Sherri Rauenzahn, Joong Sup Shim, et al.Nature Communications|November 12, 2024
Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trialMarina Baretti, Ludmila Danilova, Jennifer N Durham, et al.Nature Communications|June 20, 2023
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinomaThatcher Heumann, Carol Judkins, Keyu Li, et al.Nature Medicine|November 25, 2025
A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trialMarina Baretti, Allison M Kirk, Brian H Ladle, et al.Pageof 5